(No ratings)
Dr. Samuel N. Smith III, DO is a pediatrician in Maitland, FL specializing in general pediatrics. He graduated from Nova Southeastern University, College of Osteopathic Medicine. Dr. Samuel N. Smith III, DO is affiliated with Orlando Health.
Dr. Samuel N. Smith III, DO graduated from Nova Southeastern University, College of Osteopathic Medicine. He completed residency at Orlando Health. He is certified by the American Board of Pediatrics and has a state license in Florida.
Medical School: Nova Southeastern University, College of Osteopathic Medicine
Residency: Orlando Health
Board Certification: American Board of Pediatrics
Licensed In: Florida
Dr. Samuel N. Smith III, DO is associated with these hospitals and organizations:
Dr. Samuel N. Smith III, DO does not have any reviews yet, be the first to leave a review of Dr. Samuel N. Smith III, DO here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Samuel N. Smith III, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Pfizer Inc. |
$297
QUILLIVANT XR $144 |
TRUMENBA $106 |
COMIRNATY $47 |
|||
|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corporation |
$222
GARDASIL $222 |
|||||
| Mylan Specialty L.P. |
$207
EpiPen $207 |
|||||
| Novo Nordisk Inc |
$204
Norditropin $99 |
$105 |
||||
| GlaxoSmithKline, LLC. |
$201
ADVAIR $30 |
Menveo $30 |
FLOVENT $24 |
FLULAVAL $17 |
$100 |
|
| Other |
$784
XOLAIR $125 |
Aptensio XR $124 |
MYDAYIS $122 |
Lupron $114 |
VYVANSE $58 |
Other $241 |
| Food and Beverage | $1,729 |
|---|---|
| Consulting Fee | $160 |
| Gift | $25 |
Dr. Samuel Smith specializes in general pediatrics. Areas of expertise for Dr. Smith include newborn care. He is a graduate of Nova Southeastern University, College of Osteopathic Medicine and a graduate of Orlando Regional Medical Center's residency program. He is professionally affiliated with AdventHealth and Orlando Health. Dr. Smith welcomes new patients at his office inOviedo, FL as reported by AdventHealth.